top of page

2025

Nov 13, 2025

Biomedicine & pharmacotherapy

117. Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male mice

Eunbi Cho 1, Jee Hyun Yi 1, Se Jin Jeon 1, Dae Hyun Kim, Huiyoung Kwon, Jieun Jeon, 

Kyoung Ja Kwon, Dong Pyo Jang, Minho Moon *, Chan Young Shin *, Dong Hyun Kim *

Oct 31, 2025

Pharmaceutics

116. Amodiaquine Modulates Aggregation and Disassembly of Amyloid-β and Tau and Attenuates Neuroinflammatory Responses and Aβ Production

Sinae Jang 1, Sujin Kim 1, Na-Hyun Kim, Soo Jung Shin, Vijay Kumar, Jeong Gyu Son, Minseok Lee, Choon-gil Kim, Eun-Kyung Lim, Hyunju Chung, Young Ho Koh, Yunkwon Nam *, Minho Moon *

Nov 6, 2025

Food & function

115. Fucoxanthin suppresses amyloid-β and pyroglutamate-3-Aβ accumulation by modulating the PI3K/Akt/GSK-3β signaling pathway

Sep 5, 2025

Biomedicine & Pharmacotherapy

114. Taurine suppresses Aβ aggregation and attenuates Alzheimer's disease pathologies in 5XFAD mice and patient-derived cerebral organoids

Jun 9, 2025

Molecular Neurobiology

113. Localization and Pathological Implications of Lipopolysaccharide in the Brains of 5XFAD Mice

May 15, 2025

International Journal of Molecular Sciences

112. INO10, a Chaga Mushroom Extract, Alleviates Alzheimer's Disease-Related Pathology and Cognitive Deficits in 3xTg-AD Mice

Soyoung Ban 1, Thuong Thi Do, Jang-Won Pyo, Minho Moon *, Jong-Tae Park *

Mar 26, 2025

Translational Neurodegeneration

111. Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer’s disease: a comprehensive review of the characteristics and therapeutic strategies

Yunkwon Nam 1, Soo Jung Shin 1, Vijay Kumar 1, Jihyeon Won, Sujin Kim *, 

Minho Moon *

Feb 6, 2025

Biomedicine & Pharmacotherapy 

110. Liver-X receptor β-selective agonist CE9A215 regulates Alzheimer's disease-associated pathology in a 3xTg-AD mouse model

Jan 27, 2025

Translational

Neurodegeneration

109. Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives
bottom of page